1 / 12

China In Vitro Diagnostics Market

For more Info: <br><br>https://www.renub.com/china-in-vitro-diagnostics-market-is-expected-to-grow-with-19-cagr-by-2022-32-nd.php<br><br>The report China IVD Market, by Diagnostics [Clinical Chemistry, Immunoassay, Hematology, Coagulation, Microbiology, Molecular Testing, Self Monitoring of Blood Glucose (SMBG), Point of Care Testing (POCT)], Companies (Roche Diagnostics, Sysmex Corporation, Mindray Medical International Limited, Shanghai Kehua Bio-Engineering Co. Ltd., Abbott Laboratories & Others)” provides a complete analysis of China In–Vitro Diagnostics (IVD) Market. The market for China In-Vitro Diagnostics (IVD) is likely to exceed US$ 12 Billion by the end of year 2024.<br><br>Request a free sample copy of the report: <br><br>https://www.renub.com/contactus.php<br> <br>In Vitro Diagnostics (IVDs) - Devices and Reagents<br>In Vitro Diagnostics (IVDs) are medical devices and accessories that are used to perform tests on the specimens taken from the human body such as blood, urine and tissue in order to treat, mitigate, monitor drug therapies, cure, or prevent illness or its abnormality.<br>In vitro diagnostic (IVD) products are those reagents, instruments, and systems intended for use in the collection, preparation, and examination of specimens to diagnose disease or other conditions, including a decision of the state of health.<br>

renubresearch
Télécharger la présentation

China In Vitro Diagnostics Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Category: Diagnostics Market Report

  2. China IVD Market Forecast Analyst View: • China In-Vitro Diagnostics Market to exceed US$ 12 Billion by 2024. GetFree Customization in this Report • Press Release Title: • China In-Vitro Diagnostics Market to exceed US$ 12 Billion by 2024. • For more Info: • https://www.renub.com/china-in-vitro-diagnostics-market-is-expected-to-grow-with-19-cagr-by-2022-32-nd.php

  3. China In-Vitro Diagnostics Market to exceed US$ 12 Billion by 2024. • Research Report Title: • China In–Vitro Diagnostics (IVD) Market, By Diagnostics (Immunoassay, Microbiology, Molecular, SMBG, POCT & etc.) & Companies • Access Full Research: • https://www.renub.com/china-in-vitro-diagnostics-ivd-market-forecast-companies-analysis-registration-rules-1089-p.php • The report China IVD Market, by Diagnostics [Clinical Chemistry, Immunoassay, Hematology, Coagulation, Microbiology, Molecular Testing, Self Monitoring of Blood Glucose (SMBG), Point of Care Testing (POCT)], Companies (Roche Diagnostics, Sysmex Corporation, Mindray Medical International Limited, Shanghai Kehua Bio-Engineering Co. Ltd., Abbott Laboratories & Others)” provides a complete analysis of China In–Vitro Diagnostics (IVD) Market. The market for China In-Vitro Diagnostics (IVD) is likely to exceed US$ 12 Billion by the end of year 2024.

  4. China In-Vitro Diagnostics Market to exceed US$ 12 Billion by 2024. Request a free sample copy of the report: https://www.renub.com/contactus.php In Vitro Diagnostics (IVDs) - Devices and Reagents In Vitro Diagnostics (IVDs) are medical devices and accessories that are used to perform tests on the specimens taken from the human body such as blood, urine and tissue in order to treat, mitigate, monitor drug therapies, cure, or prevent illness or its abnormality. In vitro diagnostic (IVD) products are those reagents, instruments, and systems intended for use in the collection, preparation, and examination of specimens to diagnose disease or other conditions, including a decision of the state of health. A Look on China In Vitro Diagnostic (IVD) Market By Testing, the Immunoassay accounted for the largest share of the market in 2016 whileMicrobiology Market has grown approximately 4 times in 2016 compared to its market value in 2007 driven by growing prevalence of chronic lifestyle diseases, increasing aging population and demand for tests in urban and rural areas.

  5. China In-Vitro Diagnostics Market to exceed US$ 12 Billion by 2024.

  6. China In-Vitro Diagnostics Market to exceed US$ 12 Billion by 2024. In Vitro Diagnostic (IVD) Enhancing Healthcare System In vitro diagnostic (IVD) is an important segment of the healthcare industry. The market is observing rapid growth ignited by technological enhancements, better diagnostic devices and tools, advanced monitoring systems, and increased availability of over-the-counter tests. IVDs add momentous value to healing processes and medical diagnoses, strengthening the well-being of the general public. Client can Purchase this Report in Sections from below link: Access full Research:http://www.renub.com/china-in-vitro-diagnostics-ivd-market-forecast-companies-analysis-registration-rules-1089-p.php FDA Approval and Process FDA classifies IVD products into Class I, II, or III according to the level of regulatory regulations, with the aim to assure safety and effectiveness. The classification of an IVD (or other medical devices) determines the suitable premarket approval and process. •    Class I •    Class II •    Class III

  7. China In-Vitro Diagnostics Market to exceed US$ 12 Billion by 2024. The Report Studies the China (PRC) IVD Market on the basis of:  Segment Analysis (2007 – 2024) 1.    Clinical Chemistry Market 2.    Immunoassay Market 3.    Hematology Market 4.    Coagulation Market 5.    Microbiology Market6.    Molecular Testing Market7.    Self Monitoring of Blood Glucose (SMBG) Market 8.    Point of Care Testing (POCT) Market Key Players (2011 – 2024) 1.    Roche Diagnostics 2.Sysmex Corporation3. Mindray Medical International Limited4.    Shanghai Kehua Bio-Engineering Co. Ltd.5.    Abbott Laboratories6.    Others

  8. Table of Contents for China IVD Market Key Topics Covered 1. Executive Summary 2.    China IVD Market (2007 – 2024) 3.    Market Share – China In Vitro Diagnostics (IVD) (2011 – 2024) 3.1    Segments – China IVD 3.2    Companies – China IVD 4.    Segments – China IVD Market (2007 – 2024) 4.1    Clinical Chemistry Market 4.2    Immunoassay Market4.3    Hematology Market 4.4    Coagulation Market4.5    Microbiology Market 4.6    Molecular Diagnostic Market4.7    Self Monitoring of Blood Glucose (SMBG) Market4.8    Point of Care Testing (POCT) Market 5.    Development Environment of Chinese IVD Industry 5.1    Healthcare Reforms 5.2    Improving Quality at Grass-Root Level5.3    Embracing Technology

  9. Table of Contents for China IVD Market 6.    China: Health Insurance and Reimbursement Policies 6.1    Health Insurance System 6.2    Reimbursement Rules 7.    Registration of In Vitro Diagnostic Reagents in China 7.1    Registration and Filing7.2    Filing Obligation for Clinical Trials7.3    Clinical Trial Institutions7.4    Elimination of IVD Loophole for Research7.5    Change of Manufacturing Address7.6    Change of Main Supplier of an Antigen or Antibody7.7    Update on China In-Vitro Diagnostics Registration 8.    Medical Devices and Reagents Class Registration in China 8.1    Process of Medical Device Registration in China8.2    Classification of In-vitro Diagnostic Reagents in China 8.3    China In-Vitro Diagnostics Reagents

  10. Table of Contents for China IVD Market 9.    China IVD Industry Drivers 9.1    Increasing Demand from Middle Class for High Quality Healthcare Products9.2    Rising Incidences of Lifestyle Diseases in China9.3    Growth in Private Hospitals & Independent Diagnostic Centers 10.    China IVD Industry Challenges 10.1    Chinese Local Firms Lack of Expertise in Advanced Technology10.2    Cost Factor Restricts the Contribution of Global IVD Companies in the Chinese IVD Market10.3    Reimbursement Rates varies from Province to Province in China 11.    Company Sales Analysis (2011 – 2024) 11.1    Roche Diagnostics - China IVD Sales & Forecast11.2    Sysmex Corporation - China IVD Sales & Forecast11.3    Mindray Medical International Limited - China IVD Sales & Forecast11.4    Shanghai Kehua Bio-Engineering Co. Ltd. - China IVD Sales & Forecast11.5    Abbott Laboratories - China IVD Sales & Forecast11.6    Others - China IVD Sales & Forecast

  11. Table of Contents for China IVD Market 12.    Profiles of Select Private Clinical Labs and Diagnostic Services Companies 12.1    Zhejiang Di’an Diagnostics Technology Co., Ltd. 12.2    ADICON Clinical Laboratories (Privately held) 12.3    Guangzhou Kingmed Diagnostics Center Co. Ltd. 12.4    Kindstar Global (Privately held) 12.5    BGI-Shenzhen 12.6    OriGene Technologies

  12. GetFree Customization in this Report • Diagnostics Market Reports: • https://www.renub.com/diagnostics-14-c.php

More Related